Pierzynowska, Karolina
Gaffke, Lidia
Cyske, Zuzanna
Węgrzyn, Grzegorz http://orcid.org/0000-0003-4042-7466
Funding for this research was provided by:
Narodowym Centrum Nauki (2017/25/N/NZ2/00812)
Article History
Received: 17 February 2019
Accepted: 1 March 2019
First Online: 9 March 2019
Compliance with ethical standards
:
: The use of genistein in treatment of Huntington’s disease is a subject of patent application (no. P.417983, submitted to Polish Patent Office). No other conflicts of interest are declared by the authors.